Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 20246-55-3
2. Glyceryl Tripalmitoleate
3. Triglyceride Popopo
4. Hiver Oil Pt-70
5. Glycerol Tripalmitoleate
6. Tripalmitolein [inci]
7. Palmitoleic Acid Triglyceride
8. 129784-33-4
9. 9-hexadecenoic Acid, 1,1',1''-(1,2,3-propanetriyl) Ester, (9z,9'z,9''z)-
10. Tg(16:1(9z)/16:1(9z)/16:1(9z))
11. N9836937kg
12. Tg(16:1/16:1/16:1)
13. 1,2,3-tri-(9z-hexadecenoyl)-glycerol
14. 2,3-bis[[(z)-hexadec-9-enoyl]oxy]propyl (z)-hexadec-9-enoate
15. Tg 48:3
16. Glyceryl Tripalimitoleate
17. Tripalmitoleoin
18. Unii-n9836937kg
19. Lmgl03010020
20. Palmitoleoyl Triglyceride
21. 1,2,3-tripalmitoleoylglycerol
22. Schembl5705506
23. Chebi:75841
24. Dtxsid601021950
25. 134907-85-0
26. Zinc85552611
27. 1,2,3-tri-(9z)-hexadecenoylglycerol
28. 1,2,3-tri-(9z-hexadecenoyl)glycerol
29. 1,2,3-propanetriyl Ester Hexadecenoate
30. Glyceryl Tripalmitoleate, >=98%, Liquid
31. 1,2,3-propanetriyl Ester Hexadecenoic Acid
32. 1,2,3-tri-(9z-hexadecenoyl)-sn-glycerol
33. J-013144
34. Q27145586
35. Propane-1,2,3-triyl (9z,9'z,9''z)tris-hexadec-9-enoate
36. Tg [16:1(omega-7)/16:1(omega-7)/16:1(omega-7)]
37. Tg(16:1(9z)/16:1(9z)/16:1(9z)), Tripalmitolein
38. 30773-83-2
| Molecular Weight | 801.3 g/mol |
|---|---|
| Molecular Formula | C51H92O6 |
| XLogP3 | 19.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 47 |
| Exact Mass | 800.68939065 g/mol |
| Monoisotopic Mass | 800.68939065 g/mol |
| Topological Polar Surface Area | 78.9 Ų |
| Heavy Atom Count | 57 |
| Formal Charge | 0 |
| Complexity | 917 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 3 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Tripalmitolein manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tripalmitolein, including repackagers and relabelers. The FDA regulates Tripalmitolein manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tripalmitolein API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tripalmitolein supplier is an individual or a company that provides Tripalmitolein active pharmaceutical ingredient (API) or Tripalmitolein finished formulations upon request. The Tripalmitolein suppliers may include Tripalmitolein API manufacturers, exporters, distributors and traders.
click here to find a list of Tripalmitolein suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tripalmitolein CEP of the European Pharmacopoeia monograph is often referred to as a Tripalmitolein Certificate of Suitability (COS). The purpose of a Tripalmitolein CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tripalmitolein EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tripalmitolein to their clients by showing that a Tripalmitolein CEP has been issued for it. The manufacturer submits a Tripalmitolein CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tripalmitolein CEP holder for the record. Additionally, the data presented in the Tripalmitolein CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tripalmitolein DMF.
A Tripalmitolein CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tripalmitolein CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tripalmitolein suppliers with CEP (COS) on PharmaCompass.
Tripalmitolein Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tripalmitolein GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tripalmitolein GMP manufacturer or Tripalmitolein GMP API supplier for your needs.
A Tripalmitolein CoA (Certificate of Analysis) is a formal document that attests to Tripalmitolein's compliance with Tripalmitolein specifications and serves as a tool for batch-level quality control.
Tripalmitolein CoA mostly includes findings from lab analyses of a specific batch. For each Tripalmitolein CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tripalmitolein may be tested according to a variety of international standards, such as European Pharmacopoeia (Tripalmitolein EP), Tripalmitolein JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tripalmitolein USP).
LOOKING FOR A SUPPLIER?
